We mainly focus on mechanisms and clinical outcomes of type 2 diabetes mellitus (T2DM), address the apparent paradox of how impaired neuronal insulin can protect from the development of neurodegenerative disorders and propose astrocytic insulin signalling as a new target to explore. The gene discussed is INS; the disease is diabetes mellitus.